About Axience
Axience is a company based in Pantin (France) founded in 2001 by Laurent Flaus was acquired by Motion Equity Partners in February 2024. It operates as a Reseller / Distribution. Axience offers products and services including Veterinary Anesthesia Products, Veterinary Analgesia Products, and Hygiene and Disinfection Products. Axience operates in a competitive market with competitors including Zoetis, Ceva, PetMedix, QBiotics and Bio-Sourcing, among others.
- Headquarter Pantin, France
- Founders Laurent Flaus
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Axience Sas
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Motion Equity Partners
(Feb 28, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Axience
Axience offers a comprehensive portfolio of products and services, including Veterinary Anesthesia Products, Veterinary Analgesia Products, and Hygiene and Disinfection Products.
Products for anesthesia are provided for animal care.
Analgesia solutions are offered for managing animal pain.
Hygiene products are supplied for veterinary clinic use.
Funding Insights of Axience
Detailed funding history for Axience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Axience
Axience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Motion Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A European mid-market private equity firm is operated.
|
Locked | Locked | Locked |
Investor details for Axience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Axience
Investment portfolio details for Axience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Axience
Detailed financials for Axience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Axience Comparisons
Peer comparison for Axience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Axience
Axience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, PetMedix, QBiotics and Bio-Sourcing, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| Locked | Locked | Locked |
Developer of monoclonal antibody therapeutics for pets
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
|
| Locked | Locked | Locked |
Manufacturer of animal vaccines and healthcare products
|
Detailed competitors of Axience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Axience
Complete news archive for Axience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axience
Axience was founded in 2001.
Axience is headquartered in Pantin, France. It is registered at Pantin, Ile-de-france, France.
Laurent Flaus is the current CEO of Axience. They have also founded this company.
Axience is dedicated to animal health, distributing veterinary products across France. The company specializes in anesthesia, analgesia, and hygiene solutions for both companion and farm animals. Products are marketed to support veterinarians in providing optimal care. Sectors served include veterinary clinics and animal husbandry. Additionally, environmental initiatives like species conservation are supported through partnerships.
Axience offers Veterinary Anesthesia Products, Veterinary Analgesia Products, and Hygiene and Disinfection Products.
Axience has 1 investor. Key investors include Motion Equity Partners.